CMV p65 anticorps

N° du produit ABIN6941309

Détail du produit anti-CMV p65 anticorps

Antigène: CMV p65 (Cytomegalovirus p65 (CMV p65))

Reactivité: Human Herpesvirus 5 (HHV-5)

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp CMV p65 est non-conjugé

Application: ELISA, Coating (Coat)

Purification: Purified by Protein A/G

Immunogène: Recombinant CMV-p65 protein

Clone: CMV100

Isotype: IgG1 kappa

Information d'application

Indications d'application:

Positive Control: CMV-infected cells. Tissues.

Known Application: ELISA (For coating use Ab at 1-5 μg/mL, order Ab without BSA), Optimal dilution for a specific application should be determined.

Restrictions: For Research Use only

Stockage

Concentration: 200 μg/mL

Buffer: 10 mM PBS with 0.05 % BSA & 0.05 % azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C

Stockage commentaire: Antibody with azide - store at 2 to 8°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

Date de péremption: 24 months

Détails sur CMV p65

Antigène: CMV p65 (Cytomegalovirus p65 (CMV p65))

Autre désignation: Cytomegalovirus p65 (CMV-p65) (CMV p65 Produits)

Classe de substances: Viral Protein

Sujet: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, CMV is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of CMV disease. An indicator of active CMV infection is needed to facilitate the diagnosis of CMV disease in patients with AIDS or HIV infection. CMV p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease.

Poids moléculaire: 65kDa